Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ II.B.001 Neutrophilia ++ Graphic Jump LocationView Full Size||Download Slide (.ppt) II.B.001 Neutrophilia. Blood film. Marked increase in neutrophils in a case of metastatic carcinoma. Toxic granulation (visible purple granules) is present in the neutrophils. A lymphocyte is present in the center of the field (asterisk) and two monocytes are evident, marked by the asterisks. Two of the neutrophils are band forms; the rest are segmented forms. +++ II.B.002 Neutrophilia ++ Graphic Jump LocationView Full Size||Download Slide (.ppt) II.B.002 Neutrophilia. (A, B). Blood films. Increased neutrophils in response to a bacterial infection. Note high proportion of band neutrophils, usually representing less than 1 percent of blood neutrophil population in the normal steady-state. +++ II.B.003 Neutrophilia. Toxic Granulations ++ Graphic Jump LocationView Full Size||Download Slide (.ppt) II.B.003 Neutrophilia. Toxic Granulations. Blood film. Three segmented and one band neutrophil. Note prominent cytoplasmic granulation evident often in neutrophils in inflammatory states. Recall, individual normal specific neutrophil granules can not be resolved by light microscopy. Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Download the Access App: iOS | Android Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.